tiprankstipranks
Trending News
More News >

Portfolio 1 - New Portfolio

John Bender

Portfolio 1
Individual Investor
Ranked #278,221 out of 797,087 TipRanks' Investors
Success Rate
48%
121 out of 253
profitable transactions
Average Return
12.95%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▼ 2.45%
6-Month Return▼ 3.33%
12-Month Return▲ 12.23%
YTD Return▼ 9.03%
Total Return▲ 114.27%

Best Trade

Opened at
Closed at
Gain▲ 538.65%

Bio

Income-focused Retirement Portfolio with speculative bio/pharma, EV and space positions

Performance

25.97%0-25.97%
▲ 2.92%
▲ 2.10%
▲ 5.00%
Sep 2024
▲ 10.00%
▼ 0.89%
▼ 0.40%
Oct 2024
▲ 25.97%
▲ 5.96%
▲ 12.63%
Nov 2024
▲ 5.39%
▼ 2.41%
▼ 3.22%
Dec 2024
▲ 6.04%
▲ 2.69%
▲ 5.52%
Jan 2025
▼ 12.86%
▼ 1.27%
▼ 5.53%
Feb 2025
▼ 1.80%
▼ 5.57%
▼ 11.00%
Mar 2025
▲ 3.87%
▼ 1.56%
▲ 2.54%
Apr 2025
TipRanks AverageS&P 500Investor Portfolio
▲ 2.92%▲ 2.10%▲ 5.00%
▲ 10.00%▼ 0.89%▼ 0.40%
▲ 25.97%▲ 5.96%▲ 12.63%
▲ 5.39%▼ 2.41%▼ 3.22%
▲ 6.04%▲ 2.69%▲ 5.52%
▼ 12.86%▼ 1.27%▼ 5.53%
▼ 1.80%▼ 5.57%▼ 11.00%
▲ 3.87%▼ 1.56%▲ 2.54%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Intra-Cellular Therapies
▲ 488.44%
5
Close
Apr 01, 2025
Terran Orbital Corp
▼ 83.89%
2
Close
Aug 21, 2024
Atara Biotherapeutics
▼ 94.80%
4
Close
Feb 18, 2024
Agenus
▼ 83.14%
3
Close
Feb 18, 2024
Carnival
▼ 5.19%
4
Close
Feb 18, 2024
ImmunoGen
▲ 538.65%
4
Close
Feb 18, 2024
Caribou Biosciences
▼ 29.06%
2
Close
Feb 18, 2024
Crinetics Pharmaceuticals
▲ 104.88%
2
Close
Feb 18, 2024
Cyclo Therapeutics
▼ 6.88%
2
Close
Feb 18, 2024
Precision BioSciences
▼ 71.79%
3
Close
Feb 18, 2024
Capital Southwest
▲ 45.75%
2
Close
Feb 18, 2024
Axsome Therapeutics
▲ 105.56%
3
Close
Feb 18, 2024
Spyre Therapeutics
▼ 9.83%
2
Close
Feb 18, 2024
Allogene Therapeutics
▼ 38.85%
3
Close
Feb 18, 2024
Alpine Immune Sciences
▲ 428.93%
2
Close
Feb 18, 2024
Altimmune
▲ 23.95%
3
Close
Feb 18, 2024
ProShares MSCI Transformational Changes ETF
▲ 31.56%
2
Close
Feb 18, 2024
ARK Innovation ETF
▲ 31.48%
3
Close
Feb 18, 2024
Arcutis Biotherapeutics
▼ 41.09%
3
Close
Feb 18, 2024
Astra Space
▼ 79.27%
3
Close
Feb 18, 2024